Shockwave Tissue Regeneration Therapy Podcast

“I did two minutes of therapy onto his knee, at which time he got up and walked around like there was no problem.”

Dr. Alexander Frank first encountered shockwave therapy when his father was struggling just to get out of the car. Two minutes of treatment later, he says his father was walking around the conference floor. 

It’s the kind of story that makes you want to ask more questions. And at The National by th...

"This must be a placebo..." Then the pain was gone. 

After spending nearly a decade searching for relief from a wrist injury that ended his chiropractic career, Dr. Matt DiDuro had every reason to be skeptical. But one three-minute treatment changed his perspective and ultimately led him to dedicate his career to helping other healthcare providers discover shockwave therapy. 

In this episode, you'll learn:

• How one treatm...

"Two treatments... and my knee was bulletproof."

One successful treatment can change a life. It can also change a career.

In this episode of the Shockwave Tissue Regeneration Therapy Podcast, host Thomas Helfrich talks with Eric Brown, a former Army National Guard pilot, commercial airline captain, and longtime SoftWave advocate. After years of living with chronic knee pain and facing the possibility of another surgery, Eric discover...

What should healthcare providers look for before trusting a shockwave therapy device?

Host Thomas Helfrich and SoftWave CEO Thomas Rhoads explore what it really means for a medical technology to be backed by evidence. Together, they discuss how clinical trials are conducted, why FDA clearance is based on device-specific data, and why independent research should play a central role in evaluating shockwave therapy technology.

In this e...

"Only a couple actually have FDA clearance. The rest are knockoffs..."

When every device promises results, what should healthcare providers actually be evaluating?

Host Thomas Helfrich sits down with Thomas Rhoads, CEO of SoftWave to explore what device-specific clinical evidence actually tells you and why total cost of ownership goes far beyond the purchase price. They also discuss FDA clearance, maintenance requirements, safety sta...

Just because it says "shockwave" doesn't mean it is.

As shockwave therapy becomes more popular, more devices are entering the market. But are they all delivering the same treatment?

Thomas Helfrich and Tom Rhoads take an honest look at the current state of the industry, exploring why clinical evidence and FDA clearance matter, how some devices rely on the reputation of shockwave therapy without delivering true shockwaves, and what bo...

"It doesn't cause trauma. It's just waking the body up."

What if your body already knows how to heal, it just needs the right signal to start again?

In Episode 2 of the Shockwave Tissue Regeneration Therapy Podcast, host Thomas Helfrich and SoftWave CEO Tom Rhoads break down the science behind shockwave therapy: what happens inside the body during treatment, why the goal isn't to damage tissue but to activate your body's own healing...

“Shockwave therapy, and then dead silence”

Why haven’t you heard of shockwave therapy? 

It's been used for years, backed by hundreds of clinical studies, and helping patients around the world, yet many people are only discovering it now. So why has it stayed under the radar?

In the very first episode of the Shockwave Tissue Regeneration Therapy Podcast, host Thomas Helfrich sits down with Tom Rhoads, CEO of Soft...

This is the truth about shockwave, told through the lens of FDA-cleared technology, the providers who use it, the researchers who study it, the industry leaders who built it, and the patients living with the results.

In this welcome episode, host Thomas Helfrich shares his personal experience with shockwave therapy and the mission of the Shockwave Tissue Regeneration Therapy Podcast: no hype, no sales pitch, just evidence.

You'll dis...